Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9184 |
High Similarity |
NPD1653 |
Approved |
0.9021 |
High Similarity |
NPD7266 |
Discontinued |
0.8571 |
High Similarity |
NPD7054 |
Approved |
0.8521 |
High Similarity |
NPD3027 |
Phase 3 |
0.8519 |
High Similarity |
NPD7472 |
Approved |
0.8519 |
High Similarity |
NPD7074 |
Phase 3 |
0.8472 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8472 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8395 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8253 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8242 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD37 |
Approved |
0.8101 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8063 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7976 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7975 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7821 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7798 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7240 |
Approved |
0.773 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7724 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7586 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7584 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7561 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7531 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6842 |
Approved |
0.75 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7418 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7326 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD228 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7193 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7133 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7103 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD3748 |
Approved |
0.6981 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6981 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD5588 |
Approved |
0.6979 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6975 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6974 |
Remote Similarity |
NPD3225 |
Approved |
0.6972 |
Remote Similarity |
NPD2684 |
Approved |
0.6964 |
Remote Similarity |
NPD6386 |
Approved |
0.6964 |
Remote Similarity |
NPD6385 |
Approved |
0.6963 |
Remote Similarity |
NPD7583 |
Approved |
0.6959 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6957 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6954 |
Remote Similarity |
NPD5242 |
Approved |
0.6948 |
Remote Similarity |
NPD9494 |
Approved |
0.6943 |
Remote Similarity |
NPD4140 |
Approved |
0.6937 |
Remote Similarity |
NPD6099 |
Approved |
0.6937 |
Remote Similarity |
NPD6100 |
Approved |
0.6936 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6933 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2797 |
Approved |
0.6923 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD919 |
Approved |
0.6914 |
Remote Similarity |
NPD3060 |
Approved |
0.6909 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6909 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6903 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7584 |
Approved |
0.6871 |
Remote Similarity |
NPD6671 |
Approved |
0.6863
|
Remote Similarity |
NPD8651 |
Approved |